The Pharmacy Hub (BPI): Compounding Pharmacy Profile (2026), Providers That Use It and How to Verify It

The Pharmacy Hub (BPI) is a compounding pharmacy named by 3 telehealth providers in our database as a source of compounded GLP-1 medication. Everything below is either a provider's statement, a public record we have noted for verification, or our own note; nothing on this page is a finding about the pharmacy's quality.

Facts recorded

• Stated designation: 503A (provider-stated) (as described by the providers that name it; 503A/503B status must be confirmed on the FDA's registered outsourcing-facility list and the state board).
• Location: not recorded.
• Formulations providers attribute to it: compounded semaglutide, compounded tirzepatide.
• PCAB accreditation: not checked.
• State licenses: not checked; use the state board lookup for your state.
• Verification status: pending.

Providers that name this pharmacy

• Orderly Meds — 503A (provider-stated for all named pharmacies; a separate page refers to 503A or 503B)
• Fifty 410 — 503A (provider-stated)
• Zappy Health — 503A (The Pharmacy Hub, provider-stated)

How to verify it before your first dose

1. Confirm with your provider, in writing, that this pharmacy will fill your prescription; several providers assign pharmacies by patient and state.
2. Look up the pharmacy on your state board of pharmacy's license search (nonresident pharmacies must hold a permit to ship into your state) and on the NABP.
3. If the provider describes it as 503B, confirm it appears on the FDA's registered outsourcing-facility list; if 503A, confirm the state license and ask about PCAB accreditation (ACHC directory).
4. Ask for a certificate of analysis for your batch showing potency, sterility and endotoxin results, and confirm the active ingredient is the base form of the peptide.
5. Search the FDA warning-letter database for the pharmacy's name.

The pharmacy verification guide explains each step and the directory shows the whole provider-to-pharmacy graph.